Doximity (DOCS) is a publicly traded Clinical Workflow Platforms company founded in 2010 and based in San Francisco, United States.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Jun 24, 2021 | IPO | $494.3M | $4.6B | — |
| Apr 29, 2014 | Series C | $54M | — |
| DFJ (Draper Fisher Jurvetson), T. Rowe Price |
| Sep 5, 2012 | Series B | $17M | — | Morgenthaler Ventures |
| Mar 16, 2011 | Series A | $10.8M | — | Emergence Capital Partners, InterWest Partners |
Doximity reported fiscal Q2 2027 (quarter ended September 30, 2026) revenue of $174.5 million, up 4% year-over-year from $168.5 million. GAAP net income was $34.7 million (19.9% margin) versus $62.1 million (36.8% margin) a year earlier; GAAP diluted EPS was $0.18 versus $0.31. Adjusted EBITDA was $88.9 million, down 12% year-over-year, with a 50.9% margin versus 59.8%. GAAP operating income was $43.9 million versus $63.7 million. Operating cash flow was $93.3 million and free cash flow was $91.3 million, each roughly flat year-over-year. Operationally, the CEO said more than 190 health systems have purchased the company's AI suite, and the release cites UpToDate and DoseCheck as distribution and trust advantages. Guidance: fiscal Q3 (ending December 31, 2026) revenue of $195–196 million and adjusted EBITDA of $102.5–103.5 million; updated fiscal 2027 (ending March 31, 2027) revenue of $678–683 million and adjusted EBITDA of $317–325 million.
Q3 FY2027 revenue $195–196M, adjusted EBITDA $102.5–103.5M; FY2027 revenue $678–683M, adjusted EBITDA $317–325M (updated)
Doximity brings its clinical AI tools to NewYork-Presbyterian, a deployment with a major health system.

Doximity deploys its clinical AI tools across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine.

Doximity unveils an AI dosing tool for clinicians, with the article questioning what the product actually does.

Doximity benchmark finds popular AI models make potentially lethal dosing errors in clinical scenarios.

Doximity research finds its dose verification tool outperforms general-use AI models, which it says make dosing errors, some dangerous.
Doximity Ask ranks first against frontier AI models on the NOHARM clinical safety benchmark.
Doximity Dialer is a telehealth platform built specifically for physicians that enables HIPAA-compliant video visits and phone calls with patients. It integrates directly with the Doximity network, allowing doctors to connect with patients using their preferred phone number while keeping their personal number private. Used by over 100,000 physicians across the US, it streamlines virtual care without requiring patients to download a separate app.
Doximity Fax is a digital fax service designed to replace traditional fax machines in healthcare settings. It allows physicians to send, receive, and sign documents securely from their smartphone, tablet, or computer. Integrated with the Doximity network, it eliminates the need for physical fax hardware and paper, speeding up clinical workflows and referrals while maintaining HIPAA compliance.
Doximity's core professional networking platform connects over 80% of US physicians and 65% of nurse practitioners and physician assistants. It provides curated medical news, peer collaboration tools, secure messaging, and a digital directory of healthcare professionals. The platform also includes career management features such as job listings, salary benchmarking, and continuing medical education resources, serving as the digital backbone for the medical community.
Doximity AI Scribe, powered by DoxGPT, is an ambient AI documentation tool that automatically generates clinical notes from patient visits. It listens to physician-patient conversations in real time and produces structured medical documentation directly within the EHR workflow. Designed to reduce physician burnout by eliminating manual charting, it allows doctors to focus on patient care rather than administrative data entry.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗